The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rapifen 500 micrograms/ml solution for injection or infusion

500 microgram(s)/millilitre Solution for injection/infusion

Piramal Critical Care B.V.PA22583/001/001

Main Information

Trade NameRapifen 500 micrograms/ml solution for injection or infusion
Active SubstancesALFENTANIL HYDROCHLORIDE
Strength500 microgram(s)/millilitre
Dosage FormSolution for injection/infusion
Licence HolderPiramal Critical Care B.V.
Licence NumberPA22583/001/001

Group Information

ATC CodeN01AH Opioid anesthetics
N01AH02 alfentanil

Status

Authorised/WithdrawnAuthorised
Licence Issued09/06/1992
Legal statusNot applicable
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back